ストックスクリーナーアプリを入手
63.50
1.23%
-0.73
アフターアワーズ：
63.00
-0.50
-0.79%
Henry Schein Inc (HSIC) 最新ニュース
Henry Schein to Present at November Conferences - Dentistry Today
Henry Schein (Nasdaq: HSIC) to present at Stifel Nov 12, Jefferies Nov 18; live webcasts - Stock Titan
Henry Schein to Participate in Upcoming Investor Conferences in November - Bluefield Daily Telegraph
Will earnings trigger a reversal in Henry Schein Inc.July 2025 Reactions & Consistent Return Strategy Ideas - newser.com
Analyzing drawdowns of Henry Schein Inc. with statistical toolsMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Has Henry Schein Inc. found a price floorGDP Growth & Stock Portfolio Risk Control - newser.com
Will Henry Schein Inc. bounce back from current support2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Henry Schein to Report Q3 2025 Earnings - Dentistry Today
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET - BioSpace
Earnings Preview: What to Expect From Henry Schein’s Report - inkl
Why Henry Schein Inc. stock could be next big winnerTrade Entry Report & Fast Exit and Entry Trade Guides - nchmf.gov.vn
Understanding Henry Schein Inc.’s price movementLong Setup & Fast Momentum Entry Tips - newser.com
Is Henry Schein Inc. stock bottoming outTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo
Can Henry Schein Inc. stock hit analyst price targetsDollar Strength & Fast Gain Stock Trading Tips - newser.com
Chart based analysis of Henry Schein Inc. trendsLayoff News & Weekly Momentum Stock Picks - newser.com
Henry Schein Inc Stock Analysis and ForecastReal-Time Stock Alerts & Capitalize On Momentum - earlytimes.in
Why Henry Schein Inc. stock is trending among retail traders2025 Technical Patterns & Fast Entry Momentum Trade Alerts - nchmf.gov.vn
Gains Recap: Why Henry Schein Inc. stock is considered a top pickWeekly Earnings Recap & Free Accurate Trade Setup Notifications - nchmf.gov.vn
Henry Schein (HSIC): Evaluating Valuation After New Biomerica Deal and Analyst Downgrade - Sahm
How Henry Schein Inc. stock responds to policy changesWeekly Trend Report & Daily Risk Controlled Trade Plans - nchmf.gov.vn
Why Henry Schein Inc. stock is considered a top pickMarket Performance Summary & Free Long-Term Investment Growth Plans - nchmf.gov.vn
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
What dividend safety score for Henry Schein Inc. stockWeekly Investment Summary & Growth Focused Entry Point Reports - nchmf.gov.vn
S P Trends: What dividend safety score for Henry Schein Inc. stockMarket Sentiment Report & Community Consensus Picks - nchmf.gov.vn
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S. - MarketScreener
Henry Schein (HSIC) Gets a Hold from Leerink Partners - The Globe and Mail
Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Healt... - ADVFN
Henry Schein Announces $400 Million Increase to Share Repurchase Plan - ADVFN
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. - ADVFN
How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative - Yahoo Finance
Assessing Henry Schein (HSIC) Valuation After Recent Share Price Decline - Yahoo Finance
TAG Expands Tech With Planmeca Partnership - Dentistry Today
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's Infoods®? Ibs Test in the U.S - MarketScreener
Biomerica (BMRA) Partners with Henry Schein to Expand IBS Test R - GuruFocus
Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US - MarketScreener
Henry Schein and Biomerica enter into marketing services agreement for Biomerica's inFoods IBS Test in the US - MarketScreener
59.6% of treated patients hit FDA abdominal pain endpoint; Biomerica, Henry Schein to market inFoods® in U.S. (ex NY) - Stock Titan
CFRA downgrades Henry Schein (HSIC) to a Sell - The Globe and Mail
4.29%
4.55%
大文字化:
|
ボリューム (24 時間):